Finding 1078053 (2023-003)

Material Weakness
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2024-10-02
Audit: 323671
Organization: New Reach, Inc. (CT)
Auditor: Whittlesey PC

AI Summary

  • Core Issue: The Organization lacks documentation for its cost allocation plan (CAP), leading to unsupported cost allocations for federal awards.
  • Impacted Requirements: Compliance with Title 2 U.S. Code of Federal Regulations Part 200, which mandates reasonable and documented cost allocation methodologies.
  • Recommended Follow-Up: Establish and maintain proper documentation for cost allocations, regularly update the CAP, and ensure Board approval for any changes.

Finding Text

Finding No. 2023-003: Activities Allowed or Unallowed and Allowable Costs/Cost Principles – Material Weakness Federal Program Name: All Pass-through Entity: All Federal Assistance Listing Number: All Criteria Title 2 U.S. Code of Federal Regulations Part 200 establishes cost principles for determining costs applicable to federal awards. These principles include the requirement that cost allocation methodologies be reasonable and documented and that all expenses charged to federal awards are appropriately supported. The cost allocations should be reviewed and updated for changes to operations. Condition The Organization was unable to produce documentation supporting its cost allocation plan (“CAP”). Operating expenditures reported on submitted grant reports did not consistently reconcile directly back to the underlying accounting records. Cause The Organization was unable to produce support for the allocation of costs to federal awards. The CAP has not been updated regularly. Effect The basis for computing and allocating costs to federal awards according to the CAP is unsupported. Questioned Costs Unknown. Context The Organization is unable to document the basis for allocating costs to its federal awards. Recommendation We recommend that the Organization document its basis for allocating costs to federal awards, and that the supporting documentation and related reconciliations be retained, in accordance with the Uniform Guidance. The CAP should be reviewed periodically and updated for changes in operations as deemed necessary, and approved by the Board of Directors. Management’s Response/View of Responsible Officials Management agrees with this finding, see the Corrective Action Plan

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 501576 2023-001
    Material Weakness Repeat
  • 501577 2023-001
    Material Weakness Repeat
  • 501578 2023-001
    Material Weakness Repeat
  • 501579 2023-001
    Material Weakness Repeat
  • 501580 2023-001
    Material Weakness Repeat
  • 501581 2023-001
    Material Weakness Repeat
  • 501582 2023-001
    Material Weakness Repeat
  • 501583 2023-001
    Material Weakness Repeat
  • 501584 2023-001
    Material Weakness Repeat
  • 501585 2023-001
    Material Weakness Repeat
  • 501586 2023-001
    Material Weakness Repeat
  • 501587 2023-001
    Material Weakness Repeat
  • 501588 2023-001
    Material Weakness Repeat
  • 501589 2023-001
    Material Weakness Repeat
  • 501590 2023-001
    Material Weakness Repeat
  • 501591 2023-001
    Material Weakness Repeat
  • 501592 2023-001
    Material Weakness Repeat
  • 501593 2023-002
    Significant Deficiency Repeat
  • 501594 2023-002
    Significant Deficiency Repeat
  • 501595 2023-002
    Significant Deficiency Repeat
  • 501596 2023-002
    Significant Deficiency Repeat
  • 501597 2023-002
    Significant Deficiency Repeat
  • 501598 2023-002
    Significant Deficiency Repeat
  • 501599 2023-002
    Significant Deficiency Repeat
  • 501600 2023-002
    Significant Deficiency Repeat
  • 501601 2023-002
    Significant Deficiency Repeat
  • 501602 2023-002
    Significant Deficiency Repeat
  • 501603 2023-002
    Significant Deficiency Repeat
  • 501604 2023-002
    Significant Deficiency Repeat
  • 501605 2023-002
    Significant Deficiency Repeat
  • 501606 2023-002
    Significant Deficiency Repeat
  • 501607 2023-002
    Significant Deficiency Repeat
  • 501608 2023-002
    Significant Deficiency Repeat
  • 501609 2023-002
    Significant Deficiency Repeat
  • 501610 2023-003
    Material Weakness
  • 501611 2023-003
    Material Weakness
  • 501612 2023-003
    Material Weakness
  • 501613 2023-003
    Material Weakness
  • 501614 2023-003
    Material Weakness
  • 501615 2023-003
    Material Weakness
  • 501616 2023-003
    Material Weakness
  • 501617 2023-003
    Material Weakness
  • 501618 2023-003
    Material Weakness
  • 501619 2023-003
    Material Weakness
  • 501620 2023-003
    Material Weakness
  • 501621 2023-003
    Material Weakness
  • 501622 2023-003
    Material Weakness
  • 501623 2023-003
    Material Weakness
  • 501624 2023-003
    Material Weakness
  • 501625 2023-003
    Material Weakness
  • 501626 2023-003
    Material Weakness
  • 501627 2023-004
    Material Weakness
  • 501628 2023-004
    Material Weakness
  • 501629 2023-004
    Material Weakness
  • 501630 2023-004
    Material Weakness
  • 501631 2023-004
    Material Weakness
  • 501632 2023-004
    Material Weakness
  • 501633 2023-004
    Material Weakness
  • 501634 2023-004
    Material Weakness
  • 501635 2023-004
    Material Weakness
  • 501636 2023-004
    Material Weakness
  • 501637 2023-004
    Material Weakness
  • 501638 2023-004
    Material Weakness
  • 501639 2023-004
    Material Weakness
  • 501640 2023-004
    Material Weakness
  • 501641 2023-004
    Material Weakness
  • 501642 2023-004
    Material Weakness
  • 501643 2023-004
    Material Weakness
  • 1078018 2023-001
    Material Weakness Repeat
  • 1078019 2023-001
    Material Weakness Repeat
  • 1078020 2023-001
    Material Weakness Repeat
  • 1078021 2023-001
    Material Weakness Repeat
  • 1078022 2023-001
    Material Weakness Repeat
  • 1078023 2023-001
    Material Weakness Repeat
  • 1078024 2023-001
    Material Weakness Repeat
  • 1078025 2023-001
    Material Weakness Repeat
  • 1078026 2023-001
    Material Weakness Repeat
  • 1078027 2023-001
    Material Weakness Repeat
  • 1078028 2023-001
    Material Weakness Repeat
  • 1078029 2023-001
    Material Weakness Repeat
  • 1078030 2023-001
    Material Weakness Repeat
  • 1078031 2023-001
    Material Weakness Repeat
  • 1078032 2023-001
    Material Weakness Repeat
  • 1078033 2023-001
    Material Weakness Repeat
  • 1078034 2023-001
    Material Weakness Repeat
  • 1078035 2023-002
    Significant Deficiency Repeat
  • 1078036 2023-002
    Significant Deficiency Repeat
  • 1078037 2023-002
    Significant Deficiency Repeat
  • 1078038 2023-002
    Significant Deficiency Repeat
  • 1078039 2023-002
    Significant Deficiency Repeat
  • 1078040 2023-002
    Significant Deficiency Repeat
  • 1078041 2023-002
    Significant Deficiency Repeat
  • 1078042 2023-002
    Significant Deficiency Repeat
  • 1078043 2023-002
    Significant Deficiency Repeat
  • 1078044 2023-002
    Significant Deficiency Repeat
  • 1078045 2023-002
    Significant Deficiency Repeat
  • 1078046 2023-002
    Significant Deficiency Repeat
  • 1078047 2023-002
    Significant Deficiency Repeat
  • 1078048 2023-002
    Significant Deficiency Repeat
  • 1078049 2023-002
    Significant Deficiency Repeat
  • 1078050 2023-002
    Significant Deficiency Repeat
  • 1078051 2023-002
    Significant Deficiency Repeat
  • 1078052 2023-003
    Material Weakness
  • 1078054 2023-003
    Material Weakness
  • 1078055 2023-003
    Material Weakness
  • 1078056 2023-003
    Material Weakness
  • 1078057 2023-003
    Material Weakness
  • 1078058 2023-003
    Material Weakness
  • 1078059 2023-003
    Material Weakness
  • 1078060 2023-003
    Material Weakness
  • 1078061 2023-003
    Material Weakness
  • 1078062 2023-003
    Material Weakness
  • 1078063 2023-003
    Material Weakness
  • 1078064 2023-003
    Material Weakness
  • 1078065 2023-003
    Material Weakness
  • 1078066 2023-003
    Material Weakness
  • 1078067 2023-003
    Material Weakness
  • 1078068 2023-003
    Material Weakness
  • 1078069 2023-004
    Material Weakness
  • 1078070 2023-004
    Material Weakness
  • 1078071 2023-004
    Material Weakness
  • 1078072 2023-004
    Material Weakness
  • 1078073 2023-004
    Material Weakness
  • 1078074 2023-004
    Material Weakness
  • 1078075 2023-004
    Material Weakness
  • 1078076 2023-004
    Material Weakness
  • 1078077 2023-004
    Material Weakness
  • 1078078 2023-004
    Material Weakness
  • 1078079 2023-004
    Material Weakness
  • 1078080 2023-004
    Material Weakness
  • 1078081 2023-004
    Material Weakness
  • 1078082 2023-004
    Material Weakness
  • 1078083 2023-004
    Material Weakness
  • 1078084 2023-004
    Material Weakness
  • 1078085 2023-004
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.667 Social Services Block Grant $560,313
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $422,580
14.241 Housing Opportunities for Persons with Aids $342,961
21.019 Coronavirus Relief Fund $306,840
14.267 Continuum of Care Program $213,234
14.218 Community Development Block Grants/entitlement Grants $144,689
14.231 Emergency Solutions Grant Program $50,570
21.027 Coronavirus State and Local Fiscal Recovery Funds $50,000